α-溴代-4-氯苯乙酮
α-溴代-4-氯苯乙酮结构式
|
常用名 | α-溴代-4-氯苯乙酮 | 英文名 | 2-Bromo-4'-chloroacetophenone |
|---|---|---|---|---|
| CAS号 | 536-38-9 | 分子量 | 233.490 | |
| 密度 | 1.6±0.1 g/cm3 | 沸点 | 289.7±15.0 °C at 760 mmHg | |
| 分子式 | C8H6BrClO | 熔点 | 95-99ºC | |
| MSDS | 中文版 美版 | 闪点 | 129.0±20.4 °C | |
| 符号 |
GHS05 |
信号词 | Danger |
|
Design, synthesis and structure-activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs.
J. Enzyme Inhib. Med. Chem. 29(6) , 846-67, (2014) Because of the pivotal role of cyclooxygenase (COX) in the inflammatory processes, non-steroidal anti-inflammatory drugs (NSAIDs) that suppress COX activities have been used clinically for the treatment of inflammatory diseases/syndromes; however, traditional... |
|
|
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
J. Med. Chem. 54 , 4042-56, (2011) Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different ta... |
期刊文献综述：
更多...